Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Medicare Part D plans in 2026 will exclude 16 commonly prescribed drugs, tighten brand-name coverage, and move more medications to higher-cost coinsurance tiers. While many Part D premiums will ...

The drug company is the 17th to agree to lower its prices as part of the administration’s Most Favored Nation initiative. It ...

Major U.S. insurers will adopt a unified prior authorization standard next year, aiming to speed care approvals, while the government has finalized a 2.48% average Medicare Advantage payment increase ...

The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock slip as health insurers remain undecided on a U.S. program to expand ...

Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump ...

The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare ...

The deal involves Regeneron lowering the prices of all its current and future drugs on Medicaid, according to Trump. It also ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

The biggest players in the health care industry are pouring record sums into K Street as the Trump administration intensifies ...